Predisposition to Colonic Dysplasia is Unaffected by Continuous Administration of Insulin-like Growth Factor-1 for Twenty Weeks in a Rat Model of Chronic Inflammatory Bowel Disease

References

• Allen D. C., Biggart J. D., Pyper P. C. Large bowel mucosal dysplasia and carcinoma in ulcerative colitis. J. Clin. Pathol 1985; 38: 30–43
   PubMed Web of Science ®Google Scholar
• Apfel S. C., Kessler J. A. Neurotrophic factors in the treatment of peripheral neuropathy. Ciba Found. Symp 1996; 196: 98–108, discussion 108–112
   PubMedGoogle Scholar
• Bastian S. E.P., Walton P. E., Wallace J. C., Ballard F. J. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR31GF-I in pregnant rats. J. Endocrinol 1993; 138: 327–336
   PubMed Web of Science ®Google Scholar
• Chan J. M., Stampfer M. J., Giovannucci E., Gann P. H., Ma J., Wilkinson P., Hennekens C. H., Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279: 564–566
   Web of Science ®Google Scholar
• Chiba T. Cell kinetics of carcinoma originating from rat colitis induced by dextran sulphate sodium. Jap. Jour. Gastroent 1993; 90(4)714–181
   Google Scholar
• Cooper H. S., Murthy S. N., Shah R. S., Sedergran D. J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest 1993; 69(2)238–249
   PubMed Web of Science ®Google Scholar
• Daughaday W. H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 1990; 127: 1–4
   PubMed Web of Science ®Google Scholar
• DeFazio A., Leary J. A., Hedley D. W., Tattersall M. H.N. Immunohistochemical detection of proliferating cells, in vivo. J. Histochem. Cytochem 1987; 35: 571–577
   PubMed Web of Science ®Google Scholar
• Del-Giudice M. E., Fantus I. G., Ezzat S., McKeown-Eyssen G., Page D., Goodwin P. J. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat 1998; 47(2)111–120
   PubMed Web of Science ®Google Scholar
• Di-Gregorio C., Losi L., Fante R., Modica S., Ghidoni M., Pedroni M., Tamassia M. G., Gafa L., Ponz-de-Leon M., Roncucci L. Histology of aberrant crypt foci in the human colon. Histopathology 1997; 30(4)328–334
   PubMed Web of Science ®Google Scholar
• Edwards P. C., Truelove S. C. The course and prognosis of ulcerative colitis. Gut 1967; 8: 15–22
   PubMedGoogle Scholar
• Eriksen E. F., Kassem M., Brixen K. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm. Res 1993; 40(1–3)95–98
   PubMedGoogle Scholar
• Guevara-Aguirre J., Vasconez O., Martinez V., Martinez A. L., Rosenbloom A. L., Diamond F. B., Jr., Gargosky S. E., Nonoshita L., Rosenfeld R. G. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. J. Clin. Endocrinol. Metab 1995; 80(4)1393–1398
   PubMed Web of Science ®Google Scholar
• Guo Y. S., Narayan S., Yallampalli C., Singh P. Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology 1992; 102(4 Pt 1)1101–1108
   PubMed Web of Science ®Google Scholar
• Hirono I., Kuhara K., Hosaka S., Tomizawa S., Golgberg L. Induction of intestinal tumours in rats by dextran sulfate sodium. J. Natl. Cancer Inst 1981; 66: 579–583
   PubMedGoogle Scholar
• Howarth G. S., Fraser R., Frisby C. L., Schirmer M. B., Yeoh E. K. Effects of insulin-like growth factor-I administration on radiation enteritis in rats. Scand. J. Gastro 1997; 32: 1118–1124
   PubMed Web of Science ®Google Scholar
• Howarth G. S., Xian C. J., Read L. C. Insulin-like growth factor-1 partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium. Scand. J. Gastro 1998a; 33: 180–190
   PubMed Web of Science ®Google Scholar
• Howarth G. S., Cool J. C., Bourne A. J., Ballard F. J., Read L. C. Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 1998b; 15: 279–292
   PubMed Web of Science ®Google Scholar
• Jenkins P. J., Fairclough P. D., Richards T., Lowe D. G., Monson J., Grossman A., Wass J. A., Besser M. Acromegaly, colonic polyps and carcinoma. Clin. Endocrinol. Oxf 1997; 47(1)17–22
   PubMed Web of Science ®Google Scholar
• Ulcerative Colitis and Crohn's Disease, a Clinician's Guide, D. P. Jewell, R. G.W. Chapman, N. Mortensen. Churchill Livingston, London 1992; 1–79
   Google Scholar
• Jones J. I., Clemmons D. R. Insulin-like growth factors and their binding proteins: Biological Actions. Endocrine Reviews 1995; 16(1)3–34
   PubMed Web of Science ®Google Scholar
• Lange D. J., Felice K. J., Festoff B. W., Gawel M. J., Gelinas D. F., Kratz R., Lai E. C., Murphy M. F., Natter H. M., Norris F. H., Rudnicki S. Recombinant human insulin-like growth factor-1 in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group. Neurology 1996; 47(4 Suppl. 2)S93–94, discussion S94–95
   Web of Science ®Google Scholar
• Laron Z., Anin S., Klipperaurbach Y., Klinger B. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 1992; 339: 1258–1261
   PubMed Web of Science ®Google Scholar
• Laron Z., Klinger B. IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin. Endocrinol. Oxf 1994; 41(5)631–638
   PubMed Web of Science ®Google Scholar
• Lemmey A. B., Martin A. A., Read L. C., Tomas F. M., Owens P. C., Ballard F. J. IGF-I and the truncated analogue des-(l-3)IGF-I enhance growth in rats after gut resection. Am. J. Physiol 1991; 260(2 Pt 1)E213–E219
   Google Scholar
• Lennard-Jones J. E., Morson B. C., Ritchie J. K., Williams C. B. Cancer surveillance in ulcerative colitis, experience over 15 years. Lancet 1983; 1: 149–152
   PubMedGoogle Scholar
• Lord A. P., Read L. C., Owens P. C., Martin A. A., Walton P. E., Ballard F. J. Rapid changes in plasma concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IGF-binding proteins during anaesthesia in young sheep. J. Endocrinol 1994; 141(3)427–437
   PubMed Web of Science ®Google Scholar
• Macaulay V. M. Insulin-like growth factors and cancer. Br. J. Cancer 1992; 65: 311–320
   PubMed Web of Science ®Google Scholar
• Malecka-Panas E., Kordek R., Biernat W., Tureaud J., Liberski P. P., Majumdar A. P. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Hepatogastroenterology 1997; 44(14)435–440
   PubMedGoogle Scholar
• Murthy S. N., Cooper H. S., Shim H., Shah R. S., Ibrahim S. A., Sedergran D. J. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Digest Dis. Sci 1993; 38(9)1722–1734
   PubMed Web of Science ®Google Scholar
• Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98(3)694–702
   PubMed Web of Science ®Google Scholar
• Owens P. C., Johnson R. J., Campbell R. G., Ballard F. J. Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. J. Endocrinol 1990; 124: 269–275
   PubMed Web of Science ®Google Scholar
• Read L. C., Lemmey A. B., Howarth G. S., Martin A. A., Tomas F. M., Ballard F. J. The gastrointestinal tract is one of the most responsive target tissues for IGF-I and its potent analogs. Modern Concepts of Insulin-like Growth Factors, E. Martin Spencer. Elsevier Science Publishing Company Inc., Amsterdam 1991; 225–234
   Google Scholar
• Read L. C., Tomas F. M., Howarth G. S., Martin A. A., Edson K., Owens P. C., Ballard F. J. IGF-I and its N-terminal modified analogs induced marked gut growth in dexamethasone-treated rats. J. Endocrinol 1992; 133: 421–431
   PubMed Web of Science ®Google Scholar
• Remade-Bonnet M., Garrouste F., El Atiq F., Rccabianca M., Marvaldi J., Pommier G. Des-(1–3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells. Int. J. Cancer 1992; 52: 910–917
   PubMed Web of Science ®Google Scholar
• Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C., Sommers S. C., Yardley J. H. Dysplasia in inflammatory bowel disease. Standardized classification with provisional clinical applications. Hum. Pathol 1983; 14: 931–968
   PubMed Web of Science ®Google Scholar
• Roncucci L., Scalmati A., Ponz-de-Leon M. Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel. Cancer 1991; 68(4)873–878
   PubMed Web of Science ®Google Scholar
• Shih S. D., Rees T. D., Miller E. G., Wright J. M., Iacopino A. M. The effects of platelet-derived growth factor-BB and insulin-like growth factor-I on epithelial dysplasia. J. Periodontol 1995; 67(11)1224–1232
   Web of Science ®Google Scholar
• Shpitz B., Bomstein Y., Mekori Y., Cohen R., Kaufman Z., Grankin M., Bernheim J. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am. J. Surg 1997; 174(4)425–430
   PubMed Web of Science ®Google Scholar
• Singh P., Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology 1993; 105(4)1218–1237
   PubMed Web of Science ®Google Scholar
• Steeb C.-B., Trahair J. F., Tomas F. M., Read L. C. Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am. J. Physiol 1994; 66(6PtI)G1090–G1098
   Google Scholar
• Tamaru T., Kobayashi H., Kishimoto S., Kajiyama G., Shimamoto F., Brown W. R. Histochemical study of colonic cancer in experimental colitis of rats. Digest. Dis. Sci 1993; 38: 529–537
   PubMed Web of Science ®Google Scholar
• Vestergaard H., Rossen M., Urhammer S. A., Muller J., Pedersen O. Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus. Eur. J. Endocrinol 1997; 136(5)475–482
   PubMed Web of Science ®Google Scholar
• Warren R. S., Yuan H., Math M. R., Ferraia N., Donner D. B. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. Biol. Chern 1996; 271(46)29483–29488
   PubMed Web of Science ®Google Scholar
• Watanabe I., Isozaki H., Toyoda M., Ishibashi T., Hara H., Niki M., Gon G., Tenjo T., Kawasaki H., Tanigawa N. Immunohistochemical study on the progression of colorectal cancer with respect to apoptotic index, expression of apoptosis-related gene products, and labeling index of proliferating cell nuclear antigen (PCNA). Gun To Kagaku Ryoho 1998; 25(Suppl. 3)410–414
   PubMedGoogle Scholar
• Welberg J. W., de-Vries E. G., Hardonk M. J., Mulder N. H., Harms G., Grond J., Zwart N., Koudstaal J., de-Ley L., Kleibeuker J. H. Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: a refined immunohistochemical method. J. Clin. Pathol 1990; 43(6)453–456
   PubMed Web of Science ®Google Scholar
• Yamada K., Yoshitake M. S., Ahnen D. Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat. Gastroenterology 1992; 103: 160–167
   PubMed Web of Science ®Google Scholar
• Yamada M., Ohkusa T., Okayasu I. Occurrence of dysplasis and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 1992; 33: 1521–1527
   PubMed Web of Science ®Google Scholar